Targeted biomarker testing for oncology, precision medicine, and treatment monitoring
IHC, FISH, and molecular testing for actionable biomarkers (PD-L1, HER2, EGFR, ALK, ROS1, etc.)
FDA/CDSCO-approved companion diagnostic tests for targeted therapy selection
Sensitive detection of MRD for treatment monitoring and relapse prediction
Cell-free DNA (cfDNA) and circulating tumor cells (CTC) analysis from blood
To order a biomarker panel test, please complete our requisition form or contact us directly.